Overview

F-18 Rhodamine 6G PET Imaging for Myocardial Blood Flow

Status:
Suspended
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Use of novel radio-pharmaceutical Rhodamine 6G to determine myocardial blood flow
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Boston Children's Hospital
Treatments:
Rhodamine 6G